1. Home
  2. INFA vs RGEN Comparison

INFA vs RGEN Comparison

Compare INFA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFA
  • RGEN
  • Stock Information
  • Founded
  • INFA 1993
  • RGEN 1981
  • Country
  • INFA United States
  • RGEN United States
  • Employees
  • INFA N/A
  • RGEN N/A
  • Industry
  • INFA EDP Services
  • RGEN Medical/Dental Instruments
  • Sector
  • INFA Technology
  • RGEN Health Care
  • Exchange
  • INFA Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • INFA 5.6B
  • RGEN 8.0B
  • IPO Year
  • INFA 2021
  • RGEN N/A
  • Fundamental
  • Price
  • INFA $24.42
  • RGEN $127.47
  • Analyst Decision
  • INFA Hold
  • RGEN Buy
  • Analyst Count
  • INFA 15
  • RGEN 12
  • Target Price
  • INFA $26.21
  • RGEN $170.40
  • AVG Volume (30 Days)
  • INFA 3.7M
  • RGEN 694.0K
  • Earning Date
  • INFA 07-29-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • INFA N/A
  • RGEN N/A
  • EPS Growth
  • INFA 215.78
  • RGEN N/A
  • EPS
  • INFA 0.00
  • RGEN N/A
  • Revenue
  • INFA $1,655,308,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • INFA $5.12
  • RGEN $13.93
  • Revenue Next Year
  • INFA $4.76
  • RGEN $14.35
  • P/E Ratio
  • INFA $3,824.02
  • RGEN N/A
  • Revenue Growth
  • INFA 2.29
  • RGEN 4.88
  • 52 Week Low
  • INFA $15.65
  • RGEN $102.97
  • 52 Week High
  • INFA $31.65
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • INFA 77.02
  • RGEN 54.11
  • Support Level
  • INFA $24.24
  • RGEN $121.44
  • Resistance Level
  • INFA $24.40
  • RGEN $131.43
  • Average True Range (ATR)
  • INFA 0.09
  • RGEN 4.47
  • MACD
  • INFA -0.16
  • RGEN 0.61
  • Stochastic Oscillator
  • INFA 82.05
  • RGEN 74.57

About INFA Informatica Inc.

Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: